Publicaciones científicas

Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides

Goodchild J, Agrawal S, Civeira MP, Sarin PS, Sun D, Zamecnik PC.
Worcester Foundation for Experimental Biology, Shrewsbury, MA 01545

Revisão:Proceedings of the National Academy of Sciences of the United States of America.

Data: 1/Ago/1988

Medicina Interna [ES]

Twenty different target sites within human immunodeficiency virus (HIV) RNA were selected for studies of inhibition of HIV replication by antisense oligonucleotides.

Target sites were selected based on their potential capacity to block recognition functions during viral replication. Antisense oligomers complementary to sites within or near the sequence repeated at the ends of retrovirus RNA (R region) and to certain splice sites were most effective. The effect of antisense oligomer length on inhibiting virus replication was also investigated, and preliminary toxicity studies in mice show that these compounds are toxic only at high levels.

The results indicate potential usefulness for these oligomers in the treatment of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex either alone or in combination with other drugs.

CITAÇÃO DO ARTIGO Proc Natl Acad Sci U S A. 1988 Aug;85(15):5507-11

tal vezLE INTERESE

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra